Furthermore, RET is one of the 59 genes for which the American College of Medical Genetics and Genomics recommends reporting as a secondary finding (i.e., reporting in individuals with no relevant history of cancer in whom whole exome sequencing or whole genome sequencing is undertaken for unrelated indications) (34, 35). Here, RET is linked to cancer.